Finance

Mga Listahan
RVTY:NYSE
Revvity Inc
$151.53
+1.66%
(+2.47) 1D
$151.53
0.00% (0.00)
Pagkalipas ng oras ng trabaho
Sarado: Okt 2, 4:02:39 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa RVTY...
Buksan
$149.94
Mataas
$153.38
Mababa
$148.55
Mkt. cap
16.91B
Avg. na dami
2.14M
Dami
1.24M
Mataas nang 52-wk
$158.28
Mababa nang 52-wk
$81.22
Beta
1.06
Mga natitirang share
111.59M
Bilang ng mga empleyado
11K
Buksan
$149.94
Mataas
$153.38
Mababa
$148.55
Mkt. cap
16.91B
Avg. na dami
2.14M
Dami
1.24M
Mataas nang 52-wk
$158.28
Mababa nang 52-wk
$81.22
Beta
1.06
Mga natitirang share
111.59M
Bilang ng mga empleyado
11K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Tungkol sa Revvity Inc
CEOPrahlad Singh
Mga Empleyado11K
Itinatag1947
HeadquartersWaltham, Massachusetts, Estados Unidos
Sektor-
Mga rating ng analyst
Batay sa 13 (na) analyst na nagbigay ng mga rating ng stock sa RVTY sa nakalipas na 3 buwan
Pagbili
Pagbili
4
Pag-hold
9
Pagbebenta
0
12 buwang forecas
Batay sa 13 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa RVTY sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $151.53
$165.00 (+8.89%)
Average
$127.36 (-15.95%)
Pinakamababa
$110.00 (-27.41%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Eve Burstein
Bernstein
Hold
Maintained
$120.00
-20.8%
09/25/2026
Evie Koslosky
Goldman Sachs
Hold
Maintained
$140.00
-7.6%
09/20/2026
Unknown Analyst
CFRA
Hold
Downgraded
-
-
09/18/2026
Unknown Analyst
UBS
Hold
Initiated
$140.00
-7.6%
09/08/2026
Doug Schenkel
UBS
Hold
Downgraded
$140.00
-7.6%
09/09/2026
Paul Knight
KeyBanc
Buy
Maintained
$165.00
+8.9%
09/04/2026
Unknown Analyst
KeyBanc
Buy
Maintained
$165.00
+8.9%
09/04/2026
Dan Leonard
RBC Capital
Hold
Initiated
$135.00
-10.9%
09/01/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
$110.00
-27.4%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$126.00
-16.8%
08/05/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
$110.00
-27.4%
08/05/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
$110.00
-27.4%
08/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
$130.00
-14.2%
08/07/2026
Luke Sergott
Barclays
Hold
Maintained
$115.00
-24.1%
08/04/2026
Puneet Souda
Leerink Partners
Buy
Reiterated
-
-
07/17/2026
Michael Polark
Wolfe Research
Hold
Initiated
-
-
06/01/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
05/14/2026
Unknown Analyst
Guggenheim
Hold
Reiterated
-
-
05/11/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$117.00
-22.8%
05/04/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
$95.00
-37.3%
04/14/2026
Jack Meehan
Nephron
Hold
Upgraded
$90.00
-40.6%
03/26/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$110.00
-27.4%
02/03/2026
Tycho Peterson
Jefferies
Hold
Maintained
$105.00
-30.7%
02/02/2026
Huling ulat
Ago 4, 2026
Fiscal period
Q2 2026
EPS / Pagtataya (USD)
$1.41 / $1.22
+15.93%lumampas
Kita / Pagtataya (USD)
729.69M / 702.97M
+3.80%lumampas
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Abr 2026
Hul 2026
Kita
698.95M
772.06M
711.12M
729.69M
Gastusin sa mga naibentang produkto
324.34M
350.40M
323.46M
312.82M
Halaga ng kita
324.34M
350.40M
323.46M
312.82M
Mga gastos sa pananaliksik at pag-develop
50.80M
58.18M
57.89M
48.97M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
227.44M
208.55M
241.91M
243.46M
Gastos sa pagpapatakbo
278.23M
266.73M
299.80M
292.43M
Kabuuang gastos sa pagpapatakbo
602.58M
617.12M
623.26M
605.25M
Kita sa pagpapatakbo
96.37M
154.93M
87.86M
124.44M
Iba pang hindi kita sa pagpapatakbo
-
-
-
-
EBT na may mga hindi karaniwang item
55.68M
91.56M
49.99M
63.53M
EBT na hindi kasama ang mga hindi karaniwang item
76.49M
133.38M
65.92M
105.36M
Gastos sa buwis sa kita
8.46M
-4.21M
9.10M
10.05M
Epektibong rate ng buwis
15.20%
-4.60%
18.20%
15.82%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
46.65M
98.36M
40.72M
51.82M
Margin ng kabuuang kita
6.67%
12.74%
5.73%
7.10%
Kita bawat share
1.18
1.70
1.06
1.41
Kita sa interes at investment
6.92M
5.75M
6.30M
5.26M
Gastos sa interes
-22.77M
-23.51M
-24.72M
-22.99M
Mga net na gastos sa interes
-15.85M
-17.76M
-18.41M
-17.73M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
198.43M
258.01M
192.91M
226.47M
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-5.07M
-
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google